Evidence map›Paper›PMID 41255690›Full record

ArticleWorld journal of clinical pediatrics2025

Giant coronary aneurysms in children with Kawasaki disease and major cardiac complications and dynamic follow-up.

Liudmila V Bregel, Olesya S Efremova, Vladimir A Podkamenny, Yurii A Kozlov, Mikhail M Kostik

Abstract read
In one paragraph

Article in World journal of clinical pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liudmila V BregelDepartment of Pediatric Cardiology, Irkutsk Regional Children's Clinical Hospital, Irkutsk 664022, Russia.
Olesya S EfremovaDepartment of Pediatric Cardiology, Irkutsk Regional Children's Clinical Hospital, Irkutsk 664022, Russia.
Vladimir A PodkamennyDepartment of Cardiovascular Surgery and Angiology, Irkutsk State Medical Academy of Postgraduate Education, A Branch of the Russian Medical Academy of Continuous Professional Education, Irkutsk 664049, Russia.
Yurii A KozlovDepartment of General Surgery, Irkutsk State Regional Children's Clinical Hospital, Irkutsk 664022, Russia.
Mikhail M KostikHospital Pediatry, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Sankt-Peterburg, Russia. kost-mikhail@yandex.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiant coronary artery aneurysms (CAA), entailing thrombosis, myocardial infarction, and sudden death, are the most severe and life-threatening complications of Kawasaki disease (KD). Giant aneurysms rarely regress and can later transform into stenoses. Data on dynamic follow-up are scarce in the literature.

aimTo evaluate clinical features and long-term outcomes of giant CAA in children with KD.

methodsA single-center retrospective study included data from patients with KD and giant CAA in the Irkutsk region (2012-2023). CAA criteria according to the American Heart Association guidelines of 2017 were used: (1) Dilated coronary artery with diameter

resultsThe mean age of children with coronary dilatation/aneurysms was 2.5 years, and the male-to-female ratio was 3:1. Patients with giant/medium CAA had symptoms of cerebral dysfunction more often compared with children with moderate (

conclusionRisk factors for giant CAA were male sex, early age, and cerebral dysfunction. Complete regression of giant coronary aneurysms occurred in 58.0% of patients after follow-up of 2.3 years.

Indexed as

ChildrenCoronary arteriesCoronary artery dilatationCoronary thrombosisGiant coronary aneurysmsKawasaki diseaseMyocardial infarction

Identifiers

PMID41255690
PMCPMC12620807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.